Puromycin-sensitive aminopeptidase limits MHC class I presentation in dendritic cells but does not affect CD8 T cell

Charles F Towne1, Ian A York, Joost Neijssen

  • 1Department of Pathology, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01655, USA.

Insights

Puromycin-sensitive aminopeptidase (PSA) may limit antigen presentation by dendritic cells, but it is not essential for generating most MHC class I peptides or for T-cell responses to viral antigens.

Area of Science:

  • Immunology
  • Molecular Biology
  • Biochemistry

Background:

  • Puromycin-sensitive aminopeptidase (PSA) is implicated in MHC class I peptide processing.
  • Its exact role in antigen presentation remains unclear.

Purpose of the Study:

  • To investigate the function of PSA in MHC class I antigen presentation.
  • To determine the necessity of PSA for generating MHC class I-presented peptides and T-cell responses.

Main Methods:

  • Generation of PSA-deficient mice and cell lines.
  • Analysis of MHC class I expression on dendritic cells and other cell types.
  • Assessment of T-cell responses to viral epitopes in PSA-deficient mice.

Main Results:

  • PSA-deficient mice exhibit reduced size and reproductive capacity.
  • Dendritic cells from PSA-deficient mice show increased surface MHC class I levels.
  • MHC class I levels and peptide precursor processing are normal in other PSA-deficient cells.
  • PSA-deficient mice maintain normal T-cell numbers and respond effectively to viral antigens.

Conclusions:

  • PSA appears to limit MHC class I antigen presentation in dendritic cells in vivo.
  • PSA is not essential for the generation of most MHC class I-presented peptides.
  • PSA is not required for stimulating T-cell responses to several tested viral antigens.

Related Concept Videos

Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Antigen Processing Pathways01:31

Antigen Processing Pathways

MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...